大阳城集团娱乐下载-首页

Home - About Us - History

MILESTONE

2017

02.20

rh-aFGF was listed in 2017 National Medical Insurance Category B

2016

11.18

The first round of financing was completed (Lead Investor: IDG)

09.19

State of the art Recombinant Batroxobin was approved to go for Phase III clinical trial

07.12

Shanghai Tenry Pharmaceutical Company Limited was established

02.16

Phase II expansion of Tenry manufacturing plant located in Fengxian was completed

2015

08.20

Tenry Production plants (Fengxian) was accredited by CFDA 2010 edition GMP

2014

10.08

Tenry production plant located in Fengxian was approved by CFDA for production of biological agent

09.16

BICI Asset was acquired and UniTao Pharmaceutical was founded

2012

10.10

Phase II production plant located in Fengxian was initiated

03.12

Shanghai Tenry Medical Technology Co., Ltd was founded

2011

11.22

Acquired the state of the art biological agent “Lyophilized Recombinant Human Acidic Fibroblast Growth Factor” Trade name: rh-aFGF for external use

2010

11.16

Shanghai Qingping Pharmaceutical Co., Ltd was acquired

09.28

Shanghai Tenry Pharmaceutical Co., Ltd was founded.